Any feedback?
Literature summary for 3.4.21.62 extracted from
- Crystallization of a nonclassical Kazal-type Carcinoscorpius rotundicauda serine protease inhibitor, CrSPI-1, complexed with subtilisin (2009), Acta Crystallogr. Sect. F, 65, 533-535.
Crystallization (Commentary)
| Crystallization (Comment) | Organism |
|---|---|
| serine protease inhibitor CrSPI-1 complexed with subtilisin. Crystals diffracted to 2.6 A resolution and belong to space group P2(1), with unit-cell parameters a = 73.8, b = 65.0, c = 111.9 A, beta = 95.4. Presence of one heterotrimer (1:2 ratio of CrSPI-1:subtilisin) and one free subtilisin molecule in the asymmetric unit | synthetic construct |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| CrSPI-1 | Kazal-type inhibitor from the hepatopancreas of the Carcinoscorpius rotundicauda, potently inhibits subtilisin | synthetic construct |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| synthetic construct | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| subtilisin | - |
synthetic construct |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
